DrugPatentWatch Database Preview
ALECENSA Drug Profile
When do Alecensa patents expire, and when can generic versions of Alecensa launch?
Alecensa is a drug marketed by Hoffmann-la Roche and is included in one NDA. There are three patents protecting this drug.
The generic ingredient in ALECENSA is alectinib hydrochloride. One supplier is listed for this compound. Additional details are available on the alectinib hydrochloride profile page.
Summary for ALECENSA
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 26 |
| Clinical Trials: | 7 |
| Patent Applications: | 35 |
| Drug Prices: | Drug price information for ALECENSA |
| DailyMed Link: | ALECENSA at DailyMed |
Generic Entry Opportunity Date for ALECENSA
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for ALECENSA
| Drug Class | Kinase Inhibitor |
| Mechanism of Action | Kinase Inhibitors |
Synonyms for ALECENSA
| 1256589-74-8 |
| 3341AH |
| 5H-Benzo[B]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-ipperidinyl]-11-oxo-, hydrochloride (1:1) |
| 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile hydrochloride (1:1) |
| 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile monohydrochloride salt |
| 9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride |
| ACN-050755 |
| AF-802 hydrochloride |
| AGN-PC-09O9BF |
| AK174941 |
| AKOS025404940 |
| Alecensa (TN) |
| Alectinib Hydrochloride |
| Alectinib hydrochloride (JAN) |
| Alectinib Hydrochloride;AF-802 Hydrochloride;CH-5424802 Hydrochloride;RG-7853 Hydrochloride;RO-5424802 Hydrochloride |
| alectinib monohydrochloride |
| AOB87772 |
| AS-17062 |
| C30H34N4O2.ClH |
| CH 5424802, Alectinib HCl |
| CH5424802 (Hydrochloride) |
| CH5424802 HCl |
| CH5424802 HCl (AF 802 HCl, Alectinib HCl) |
| CH5424802 HCl salt, Alectinib HCl salt, AF802 HCl salt |
| CH5424802 Hydrochloride |
| CH5424802(Hydrochloride) |
| CHEBI:62268 |
| CHEMBL3707320 |
| CS-3480 |
| D10450 |
| DTXSID10154841 |
| EX-A1553 |
| GYABBVHSRIHYJR-UHFFFAOYSA-N |
| HY-13011A |
| KS-00001D3B |
| MFCD27987893 |
| MolPort-039-137-749 |
| P9YY73LO6J |
| SCHEMBL14991271 |
| UNII-P9YY73LO6J |
US Patents and Regulatory Information for ALECENSA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoffmann-la Roche | ALECENSA | alectinib hydrochloride | CAPSULE;ORAL | 208434-001 | Dec 11, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Hoffmann-la Roche | ALECENSA | alectinib hydrochloride | CAPSULE;ORAL | 208434-001 | Dec 11, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Hoffmann-la Roche | ALECENSA | alectinib hydrochloride | CAPSULE;ORAL | 208434-001 | Dec 11, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for ALECENSA
Supplementary Protection Certificates for ALECENSA
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2017 00024 | Denmark | ➤ Sign Up | PRODUCT NAME: ALECTINIB, ELLER SALT ELLER SOLVAT DERAF, HERUNDER I FORM AF HYDROCHLORID; REG. NO/DATE: EU/1/16/1169/01 20170220 |
| 2017017 | Lithuania | ➤ Sign Up | PRODUCT NAME: ALEKTINIBAS ARBA JO DRUSKA, ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/16/1169 20170216 |
| 90024-2 | Sweden | ➤ Sign Up | PRODUCT NAME: ALECTINIB OR SALT OR SOLVATE THEREOF; REG. NO/DATE: EU/1/16/1169/001 20170220 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
